Tamoxifen treatment before orchiectomy in advanced breast cancer in men
Becher, R.; Höffken, K.; Pape, H.; Schmidt, C.G.
New England Journal of Medicine 305(3): 169-170
1981
ISSN/ISBN: 0028-4793 PMID: 7242589 Document Number: 176622
Document emailed within 1 workday
Related Documents
Chiesa, M.Dalla.; Passalacqua, R.; Michiara, M.; Franciosi, V.; Di Costanzo, F.; Bisagni, G.; Camisa, R.; Buti, S.; Tomasello, G.; Cocconi, G. 2007: Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial Acta Bio-Medica: Atenei Parmensis 78(3): 204-209Viladiu, P.; Bosch, F.X.; Benito, E.; Alonso, M.C. 1977: Antiestrogen tamoxifen in the treatment of advanced breast cancer: a series of 31 patients Cancer Treatment Reports 61(5): 899-900
Powles, T.J.; Gordon, C.; Coombes, R.C. 1982: Clinical trial of multiple endocrine therapy for metastatic and locally advanced breast cancer with tamoxifen-aminoglutethimide-danazol compared to tamoxifen used alone Cancer Research 42(8 Suppl): 3458s-3460s
Al-Alwan, N.A.; al-Kubaisy, W.; al-Rawaq, K. 2000: Assessment of response to tamoxifen among Iraqi patients with advanced breast cancer Eastern Mediterranean Health Journal 6(2-3): 475-482
Lorenz, I.; Mechl, Z. 1985: Medroxyprogesterone acetate versus tamoxifen in the therapy of advanced breast cancer Neoplasma 32(1): 119-124
2001: Anastrozole: licence extension. No advantage over tamoxifen in advanced-stage breast cancer Prescrire International 10(53): 76-77
Bhatavdekar, J.M.; Shah, N.G.; Patel, D.D.; Karelia, N.H.; Trivedi, S.N.; Vora, H.H.; Ghosh, N.; Giri, D.D.; Balar, D.B. 1992: Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifen Neoplasma 39(2): 123-127
Novoa Vargas, A.; Font López, K.C.; Amador, D.D. 2011: Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer Ginecologia y Obstetricia de Mexico 79(9): 553-557
Gershanovich, M.L.; Garin, A.M.; Baltinia, D.; Kurvet, A.; Kangas, L.; Ellmen, I. 1997: Results of phase Ii clinical trial of Tamoxifen and Toremifen in two different doses in advanced breast cancer in postmenopausal women Voprosy Onkologii 43(6): 587-595
Mustacchi, G.; Milani, S.; Pluchinotta, A.; De Matteis, A.; Rubagotti, A.; Perrota, A. 1994: Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: the G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly Anticancer Research 14(5b): 2197-2200
Tanaka, Y.; Ohmori, Y.; Toki, T.; Okazaki, Y.; Ogoshi, S.; Ogawa, Y. 1995: A case of advanced male breast cancer successfully treated by 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy combined with tamoxifen Nihon Geka Hokan. Archiv für Japanische Chirurgie 64(1): 15-22
Bonomi, P.; Gale, M.; Von Roenn, J.; Anderson, K.; Johnson, P.; Wolter, J.; Economou, S. 1988: Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen Seminars in Oncology 15(2 Suppl 1: 26-33
Howell, A.; Harland, R.N.; Barnes, D.M.; Baildam, A.D.; Wilkinson, M.J.; Hayward, E.; Swindell, R.; Sellwood, R.A. 1987: Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment Cancer Research 47(1): 300-304
Le Bouedec, G.; Pingeon, J.M.; Fondrinier, E.; Kauffmann, P.; Dauplat, J. 1995: Gynecologic monitoring of tamoxifen treatment of breast cancer Revue Francaise de Gynecologie et d'Obstetrique 90(7-9): 379-382
Elena, H.; Jimenez, R.; Caprarulo, L.; Asís, M.; Cassanello, G. 1992: Tamoxifen as the primary treatment for breast cancer in elderly patients Medicina 52(3): 236-239
Telhaug, R.; Fosså, S.D.; Lund, G.; Børmer, O. 1982: Hormonal treatment of breast cancer in men. Experiences with antiestrogen Tamoxifen Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 102(34-36): 1849-1851
Ondrus, D.; Hornák, M.; Matoska, J. 1993: Neo-adjuvant chemotherapy with delayed orchiectomy in patients with advanced germ cell testicular cancer Neoplasma 40(3): 189-192
Semiglazov, V.F.; Kostetskaia, T.V. 2001: Tamoxifen--"golden standard" in the treatment of patients with early breast cancer Voprosy Onkologii 47(1): 108-112
Knönagel, H.; Bolle, J.F.; Hering, F.; Senn, E.; Hodel, T.; Neuenschwander, H.; Biedermann, C. 1989: Therapy of metastatic prostatic cancer by orchiectomy plus Anandron versus orchiectomy plus placebo. Initial results of a randomized multicenter study Helvetica Chirurgica Acta 56(3): 343-345
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333